Small Cell Lung Carcinoma
Showing 1 - 25 of >10,000
Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, [89Zr]Zr-BI 764532)
Not yet recruiting
- Small Cell Lung Carcinoma (SCLC)
- Neuroendocrine Neoplasms
- BI 764532
- [89Zr]Zr-BI 764532
- (no location specified)
Jul 31, 2023
Molecular Analysis and Treatment Options of SCLC
Recruiting
- Small-cell Lung Cancer
- +4 more
-
Shanghai, ChinaShanghai Chest Hospital
Jul 6, 2023
Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Carboplatin, Etoposide)
Not yet recruiting
- Small Cell Lung Carcinoma (SCLC)
- BI 764532
- +5 more
- (no location specified)
Oct 17, 2023
Small Cell Lung Cancer, Neuroendocrine Carcinoma Trial in Zhengzhou (ZG006)
Not yet recruiting
- Small Cell Lung Cancer
- Neuroendocrine Carcinoma
- ZG006
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Aug 6, 2023
Small Cell Lung Carcinoma (SCLC), Neuroendocrine Tumors Trial (BI 764532, Ezabenlimab)
Not yet recruiting
- Small Cell Lung Carcinoma (SCLC)
- Neuroendocrine Neoplasms
- BI 764532
- Ezabenlimab
- (no location specified)
May 25, 2023
Small Cell Lung Carcinoma (SCLC) Trial (BI 764532, Topotecan)
Not yet recruiting
- Small Cell Lung Carcinoma (SCLC)
- BI 764532
- Topotecan
- (no location specified)
Aug 7, 2023
Immune Checkpoint Inhibitors in Non-Small Cell Lung Carcinoma
Active, not recruiting
- Non Small Cell Lung Cancer
- Immune signature in serum associated to the metabolic signature
- Meta-genomic signature of intestinal flora
-
La Tronche, Isère, FranceUniversity Hospital, Grenoble
Jan 6, 2023
Dietary Practices and Locally Advanced Lung Cancer (LUNGDIET)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Self-administered survey at hospital
- +2 more
- (no location specified)
Oct 3, 2023
Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)
Not yet recruiting
- Extensive Stage Small Cell Lung Cancer (ES-SCLC)
- (no location specified)
Sep 19, 2023
Stage IB Non-small Cell Lung Cancer
Completed
- Stage IB Non-Small Cell Lung Carcinoma
-
Shanghai, China180 Fenglin Road
Jul 29, 2023
Extensive Stage Small Cell Lung Cancer
Not yet recruiting
- Extensive-stage Small-cell Lung Cancer
-
Changsha, Hunan, ChinaHunan Cancer hospital
Aug 6, 2023
EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)
Recruiting
- EGFR-Mutated Non-Small-Cell Lung Carcinoma
- Small Cell/Neuroendocrine
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 20, 2023
TRAcking Non-small Cell Lung Cancer Evolution Through Therapy
Not yet recruiting
- Lung Cancer, Non-small Cell
- Small Cell Lung Cancer
- (no location specified)
Nov 16, 2022
Small Cell Lung Carcinoma, Neuroendocrine Tumors Trial (BI 764532)
Not yet recruiting
- Small Cell Lung Carcinoma
- Neuroendocrine Neoplasms
- BI 764532
- (no location specified)
May 22, 2023
Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer, Stage II Lung Cancer Trial in Nashville (drug, biological,
Not yet recruiting
- Limited Stage Lung Small Cell Carcinoma
- +3 more
- Cisplatin
- +8 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Nov 10, 2023
Participation for Small Cell Lung Cancer Patients
Not yet recruiting
- Small Cell Lung Cancer
- (no location specified)
Mar 3, 2023
Recurrent Extensive Stage Small Cell Lung Carcinoma Trial in Hangzhou, Nanjing, Zhengzhou (HTMC0435, Temozolomide)
Not yet recruiting
- Recurrent Extensive Stage Small Cell Lung Carcinoma
-
Hangzhou, China
- +2 more
Feb 5, 2023
Extensive Stage Small Cell Lung Cancer Trial (hSTC810 400 mg + Paclitaxel, hSTC810 800 mg + Paclitaxel)
Not yet recruiting
- Extensive Stage Small Cell Lung Cancer
- hSTC810 400 mg + Paclitaxel
- hSTC810 800 mg + Paclitaxel
- (no location specified)
Aug 24, 2023
NSCLC Trial in Xinxiang (CCCR-NK92 cells)
Enrolling by invitation
- Non-small Cell Lung Cancer
- CCCR-NK92 cells
-
Xinxiang, Henan, ChinaThe first Affiliated Hospital of Xinxiang Medical University
Aug 31, 2022
Immune-Connected Assays in Small Cell Lung Cancer
Recruiting
- Small Cell Lung Cancer
-
Rome, ItalyFondazione Policlinico Gemelli IRCCS
Apr 2, 2023
Stage IA Non-Small Cell Lung Carcinoma, Stage IB Non-Small Cell Lung Carcinoma, Stage IIA Non-Small Cell Lung Carcinoma Trial in
Active, not recruiting
- Stage IA Non-Small Cell Lung Carcinoma
- +3 more
- Computed Tomography Perfusion Imaging
- +2 more
-
Los Angeles, CaliforniaUSC / Norris Comprehensive Cancer Center
Aug 5, 2022
Proteomics in Small Cell Lung Cancer
Not yet recruiting
- Small Cell Lung Cancer
- (no location specified)
Nov 14, 2022